Adage Capital Partners’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $15.3M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $568K | Hold |
|
|||||
|
2019
Q4 | $1.15M | Sell |
|
|||||
|
2019
Q3 | $4.84M | Buy |
|
|||||
|
2019
Q2 | $7.24M | Buy |
|
|||||
|
2019
Q1 | $15.4M | Buy |
|
|||||
|
2018
Q4 | $8.37M | Buy |
|
|||||
|
2018
Q3 | $9.02M | Sell |
|
|||||
|
2018
Q2 | $10.9M | Sell |
|
|||||
|
2018
Q1 | $13.7M | Sell |
|
|||||
|
2017
Q4 | $28.5M | Sell |
|
|||||
|
2017
Q3 | $99.5M | Sell |
|
|||||
|
2017
Q2 | $75.1M | Sell |
|
|||||
|
2017
Q1 | $93.6M | Buy |
|
|||||
|
2016
Q4 | $95.2M | Sell |
|
|||||
|
2016
Q3 | $112M | Sell |
|
|||||
|
2016
Q2 | $97.9M | Sell |
|
|||||
|
2016
Q1 | $106M | Buy |
|
|||||
|
2015
Q4 | $96.5M | Sell |
|
|||||
|
2015
Q3 | $41M | Buy |
|
|||||
|
2015
Q2 | $48.8M | Buy |
|
|||||
|
2015
Q1 | $36.9M | Buy |
|
|||||
|
2014
Q4 | $24.8M | Buy |
|
|||||
|
2014
Q3 | $5.87M | Buy |
|
|||||
|
2014
Q2 | $1.36M | Buy |
|